Patents by Inventor Eriko Misawa
Eriko Misawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210121383Abstract: A problem of the present invention is to provide a novel composition for anti-aging. The means for solving the problem is to use one or multiple compounds such as a lophenol compound, and a cyclolanostane compound as active ingredients of the composition for anti-aging.Type: ApplicationFiled: March 18, 2019Publication date: April 29, 2021Applicant: MORINAGA MILK INDUSTRY CO., LTD.Inventors: Marie Saito, Eriko Misawa
-
Publication number: 20170319600Abstract: Provided is a matrix metalloproteinase production inhibitor which can be daily taken safely. In the matrix metalloproteinase production inhibitor, a compound selected from the group consisting of a lophenol compound and a cyclolanostane compound is used as an active ingredient.Type: ApplicationFiled: November 27, 2015Publication date: November 9, 2017Inventors: Marie SAITO, Eriko MISAWA, Miyuki TANAKA, Ruiqing YAO
-
Publication number: 20170319599Abstract: Provided is a means with which it is possible to efficiently prevent or improve symptoms caused by an imbalance of sex hormones with as little pain as possible, and which can safely be taken daily. A compound selected from the group consisting of a lophenol compound and a cyclolanostane compound is used as an active ingredient of an agent for preventing or improving symptoms caused by an imbalance of sex hormones.Type: ApplicationFiled: November 27, 2015Publication date: November 9, 2017Inventors: Eriko MISAWA, Ruiqing YAO, Marie SAITO, Miyuki TANAKA
-
Patent number: 8575142Abstract: To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance or ameliorate the pathosis, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant or, a fraction thereof containing the compound as an active ingredient.Type: GrantFiled: September 22, 2006Date of Patent: November 5, 2013Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Miyuki Tanaka, Eriko Misawa
-
Patent number: 8518924Abstract: To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity, considered to be a main factor of metabolic syndrome, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant, or a fraction thereof containing the compound as an active ingredient.Type: GrantFiled: July 21, 2010Date of Patent: August 27, 2013Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Miyuki Tanaka, Eriko Misawa
-
Patent number: 8486462Abstract: 3-O-?-D-Glucopyranosyl-4-methylergost-7-en-3-ol or a composition containing 0.001% by mass or more of the aforementioned compound, which is an extract of a plant of the family Liliaceae containing the compound or a fraction thereof, is used as an active ingredient of a hyperglycemia improving agent.Type: GrantFiled: July 25, 2008Date of Patent: July 16, 2013Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Ryuuichi Higuchi, Masanori Inagaki, Hirotoshi Hayasawa, Muneo Yamada, Miyuki Tanaka, Eriko Misawa, Noriko Wakimoto, Yousuke Itou
-
Patent number: 8377894Abstract: Compounds having a cyclolanostane skeleton such as 9,19-cyclolanostan-3-ol and 24-methylene-9,19-cyclolanostan-3-ol are used as an active ingredient of a drug and food or drink for improving pancreatic functions.Type: GrantFiled: February 28, 2006Date of Patent: February 19, 2013Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Miyuki Tanaka, Eriko Misawa, Noriko Habara, Muneo Yamada
-
Patent number: 8338403Abstract: A compound having a hyperglycemia improving effect and a hemoglobin A1c lowering action such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol is used as an active ingredient of a drug or food or drink for improving hyperglycemia.Type: GrantFiled: June 1, 2010Date of Patent: December 25, 2012Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Ryuuichi Higuchi, Masanori Inagaki, Hirotoshi Hayasawa, Muneo Yamada, Miyuki Tanaka, Eriko Misawa, Noriko Wakimoto, Yousuke Itou
-
Patent number: 8236769Abstract: To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains 3-O-?-D-glucopyranosyl-4-methylergost-7-en-3-ol, or an organic solvent extract, a hot water extract or a squeezed liquid of a plant of the family Liliaceae or a fraction thereof which contains the compound as an active ingredient.Type: GrantFiled: September 22, 2006Date of Patent: August 7, 2012Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Miyuki Tanaka, Eriko Misawa
-
Patent number: 8101594Abstract: Compounds such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol which have an activity for improving pancreatic function are used as an active ingredient of a pancreas function improving drug and food or drink.Type: GrantFiled: February 28, 2006Date of Patent: January 24, 2012Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Miyuki Tanaka, Eriko Misawa, Noriko Habara, Muneo Yamada
-
Patent number: 8093233Abstract: To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity, considered to be a main factor of metabolic syndrome, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant, or a fraction thereof containing the compound is used as an active ingredient.Type: GrantFiled: September 21, 2006Date of Patent: January 10, 2012Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Miyuki Tanaka, Eriko Misawa
-
Patent number: 7947669Abstract: To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains a compound having a cyclolanostane skeleton, or an organic solvent extract, a hot water extract of a plant of the family Liliaceae or Gramineae, or a fraction thereof which contains the compound as an active ingredient.Type: GrantFiled: September 22, 2006Date of Patent: May 24, 2011Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Miyuki Tanaka, Eriko Misawa
-
Patent number: 7846905Abstract: To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity considered to be a main factor of metabolic syndrome, there is provided an agent or a food or drink, including as an active ingredient 3-O-?-D-glucopyranosyl-4-methylergost-7-en-3-ol, an organic solvent extract, a hot water extract, a squeezed liquid of a Liliaceae plant or a fraction thereof which contains the compound.Type: GrantFiled: September 21, 2006Date of Patent: December 7, 2010Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Miyuki Tanaka, Eriko Misawa
-
Publication number: 20100286104Abstract: To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity, considered to be a main factor of metabolic syndrome, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant, or a fraction thereof containing the compound as an active ingredient.Type: ApplicationFiled: July 21, 2010Publication date: November 11, 2010Applicant: Morinaga Milk Industry Co., Ltd.Inventors: Miyuki Tanaka, Eriko Misawa
-
Patent number: 7812012Abstract: To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity, considered to be a main factor of metabolic syndrome, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant, or a fraction thereof containing the compound is used as an active ingredient.Type: GrantFiled: September 21, 2006Date of Patent: October 12, 2010Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Miyuki Tanaka, Eriko Misawa
-
Publication number: 20100240632Abstract: A compound having a hyperglycemia improving effect and a hemoglobin A1c lowering action such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol is used as an active ingredient of a drug or food or drink for improving hyperglycemia.Type: ApplicationFiled: June 1, 2010Publication date: September 23, 2010Applicant: Morinaga Milk Industry Co., Ltd.Inventors: Ryuuichi Higuchi, Masanori Inagaki, Hirotoshi Hayasawa, Muneo Yamada, Miyuki Tanaka, Eriko Misawa, Noriko Wakimoto, Yousuke Itou
-
Patent number: 7754704Abstract: A compound having a hyperglycemia improving effect and a hemoglobin A1c lowering action such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol is used as an active ingredient of a drug or food or drink for improving hyperglycemia.Type: GrantFiled: March 30, 2005Date of Patent: July 13, 2010Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Ryuuichi Higuchi, Masanori Inagaki, Hirotoshi Hayasawa, Muneo Yamada, Miyuki Tanaka, Eriko Misawa, Noriko Wakimoto, Yousuke Itou
-
Patent number: 7674784Abstract: A compound having a cyclolanostane skeleton such as 9,19-cyclolanostan-3-ol and 24-methylene-9,19-cyclolanostan-3-ol is used as an active ingredient of a drug or food or drink for improving hyperglycemia.Type: GrantFiled: March 30, 2005Date of Patent: March 9, 2010Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Ryuuichi Higuchi, Masanori Inagaki, Hirotoshi Hayasawa, Muneo Yamada, Miyuki Tanaka, Eriko Misawa, Noriko Wakimoto, Yousuke Itou
-
Publication number: 20100035851Abstract: To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains a compound having a cyclolanostane skeleton, or an organic solvent extract, a hot water extract of a plant of the family Liliaceae or Gramineae, or a fraction thereof which contains the compound as an active ingredient.Type: ApplicationFiled: September 22, 2006Publication date: February 11, 2010Applicant: Morinaga Milk Industry Co., LtdInventors: Miyuki Tanaka, Eriko Misawa
-
Publication number: 20090131388Abstract: To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance or ameliorate the pathosis, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant or, a fraction thereof containing the compound as an active ingredient.Type: ApplicationFiled: September 22, 2006Publication date: May 21, 2009Applicant: MORINAGA MILK INDUSTRY CO., LTD.Inventors: Miyuki Tanaka, Eriko Misawa